Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-30 @ 10:27 AM
Study NCT ID:
NCT06795893
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-01-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Anifrolumab PRIM Program
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-07
Start Date Type:
ACTUAL
Primary Completion Date:
2031-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-22
First Submit QC Date:
None
Study First Post Date:
2025-01-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL